ID27263A - Dihidropirimidina baru - Google Patents

Dihidropirimidina baru

Info

Publication number
ID27263A
ID27263A IDW20002111A ID20002111A ID27263A ID 27263 A ID27263 A ID 27263A ID W20002111 A IDW20002111 A ID W20002111A ID 20002111 A ID20002111 A ID 20002111A ID 27263 A ID27263 A ID 27263A
Authority
ID
Indonesia
Prior art keywords
hydropirimidine
new
new hydropirimidine
Prior art date
Application number
IDW20002111A
Other languages
English (en)
Indonesian (id)
Inventor
Jurgen Stoltefuss
Sirgfried Goldmann
Thomas Kramer
Karl-Heinz Schlemmer
Ulrich Niewohner
Arnold Paessens
Erwin Graef
Stefan Lottmann
Kark Deres
Olaf Weber
Jorn Stolting
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ID27263A publication Critical patent/ID27263A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
IDW20002111A 1998-04-18 1999-04-07 Dihidropirimidina baru ID27263A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19817264A DE19817264A1 (de) 1998-04-18 1998-04-18 Neue Dihydropyrimidine

Publications (1)

Publication Number Publication Date
ID27263A true ID27263A (id) 2001-03-22

Family

ID=7864972

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002111A ID27263A (id) 1998-04-18 1999-04-07 Dihidropirimidina baru

Country Status (37)

Country Link
US (3) US6696451B1 (xx)
EP (1) EP1080086B1 (xx)
JP (2) JP4590097B2 (xx)
KR (1) KR100636771B1 (xx)
CN (1) CN1159311C (xx)
AR (1) AR018187A1 (xx)
AT (1) ATE223401T1 (xx)
AU (1) AU740318B2 (xx)
BG (1) BG64649B1 (xx)
BR (2) BR9909730B1 (xx)
CA (1) CA2328780C (xx)
CO (1) CO5021127A1 (xx)
CU (1) CU23049A3 (xx)
CZ (1) CZ293482B6 (xx)
DE (2) DE19817264A1 (xx)
DK (1) DK1080086T3 (xx)
ES (1) ES2183548T3 (xx)
GT (1) GT199900056A (xx)
HK (1) HK1039119A1 (xx)
HU (1) HUP0102372A3 (xx)
ID (1) ID27263A (xx)
IL (2) IL138584A0 (xx)
MY (1) MY126527A (xx)
NO (2) NO321985B1 (xx)
NZ (1) NZ507569A (xx)
PE (1) PE20000427A1 (xx)
PL (1) PL193898B1 (xx)
PT (1) PT1080086E (xx)
RU (1) RU2245881C9 (xx)
SI (1) SI1080086T1 (xx)
SK (1) SK286407B6 (xx)
SV (1) SV1999000047A (xx)
TR (1) TR200003011T2 (xx)
TW (1) TW548274B (xx)
UA (1) UA63998C2 (xx)
WO (1) WO1999054326A1 (xx)
ZA (1) ZA200005136B (xx)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4289100A (en) * 1999-03-25 2000-10-16 Bayer Aktiengesellschaft Dihydropyrimidines and their use in the treatment of hepatitis
WO2000078730A1 (fr) 1999-06-23 2000-12-28 Ajinomoto Co., Inc. Nouveaux derives dihydropyrimidiniques
WO2001045712A1 (de) * 1999-12-22 2001-06-28 Bayer Aktiengesellschaft Arzneimittelkombinationen gegen virale erkrankungen
DE10012823A1 (de) * 2000-03-16 2001-09-20 Bayer Ag Arzneimittel gegen virale Erkrankungen
DE10013126A1 (de) * 2000-03-17 2001-09-20 Bayer Ag Arzneimittel gegen virale Erkrankungen
DE10013125A1 (de) * 2000-03-17 2001-09-20 Bayer Ag Arzneimittel gegen virale Erkrankungen
DE10125131A1 (de) 2001-05-23 2002-12-05 Bayer Ag Verfahren zur Spaltung des Methyl 4-(2-chlor-4-fluorphenyl)-2-(3,5-difluor-2-pyridinyl)-6-methyl-1,4-dihydro-5-pyrmidincarboxylat-Racemats
US20040092735A1 (en) * 2002-11-08 2004-05-13 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of cefuroxime sodium
CN101104604B (zh) * 2006-07-10 2011-03-02 北京摩力克科技有限公司 光学纯二氢嘧啶类化合物及其用于制备治疗和预防病毒性疾病的药物的用途
CN101104617B (zh) 2006-07-10 2010-06-23 北京摩力克科技有限公司 二氢嘧啶类化合物及其用于制备治疗和预防病毒性疾病的药物的用途
RU2452733C2 (ru) * 2007-04-27 2012-06-10 Пэдью Фарма Л.П. Антагонисты trpv1 и их применение
RU2443703C2 (ru) 2007-06-18 2012-02-27 Саншайн Лейк Фарма Ко., Лтд Бром-фенил замещенные тиазолилдигидропиримидины
BRPI0815562A2 (pt) 2007-07-12 2015-02-18 Novartis Ag Soluções farmacêuticas orais contendo telbivudina.
US20130267517A1 (en) 2012-03-31 2013-10-10 Hoffmann-La Roche Inc. Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
AU2013305390C1 (en) * 2012-08-24 2015-12-24 Ruyuan Wei Xiang Technology Co., Ltd. Dihydropyrimidine compounds and their application in pharmaceuticals
MA37942B1 (fr) 2012-09-10 2020-01-31 Hoffmann La Roche Hétéroaryldihydropyrimidines d'acide 6-aminé pour le traitement et la prophylaxie d'une infection par le virus de l'hépatite b
CN103664899B (zh) * 2012-09-11 2017-06-16 广东东阳光药业有限公司 杂芳基取代的二氢嘧啶类化合物及其在药物中的应用
CA2889892A1 (en) * 2012-11-09 2014-05-15 Indiana University Research And Technology Corporation Alternative uses for hbv assembly effectors
AU2014230083B2 (en) 2013-03-15 2019-07-25 Fisher & Paykel Healthcare Limited Components for medical circuits
BR102014028162A2 (pt) * 2013-11-12 2015-09-08 Dow Agrosciences Llc processo para fluoração de compostos
KR20160077050A (ko) 2013-11-19 2016-07-01 선샤인 레이크 파르마 컴퍼니 리미티드 다이하이드로피리미딘 화합물 및 이의 약제학적 용도
WO2015078391A1 (en) 2013-11-27 2015-06-04 Sunshine Lake Pharma Co., Ltd. Processes for preparing dihydropyrimidine derivatives and intermediates thereof
MX2016012573A (es) 2014-03-28 2018-02-19 Sunshine Lake Pharma Co Ltd Compuestos de dihidropirimidina y su aplicacion en productos farmaceuticos.
CN105153164B (zh) * 2014-05-30 2018-10-30 齐鲁制药有限公司 作为hbv抑制剂的二氢嘧啶并环衍生物
EP3150600B1 (en) * 2014-05-30 2018-06-27 Qilu Pharmaceutical Co., Ltd. Dihydropyrimido loop derivative as hbv inhibitor
CN105859708B (zh) 2015-02-07 2020-01-21 广东东阳光药业有限公司 二氢嘧啶衍生物的盐及其在药物中的应用
US11639350B2 (en) 2017-06-27 2023-05-02 Janssen Pharmaceutica Nv Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis B infections
US10759774B2 (en) 2017-09-28 2020-09-01 The Curators Of The University Of Missouri Inhibitors of hepatitis B virus targeting capsid assembly
EP3704127A1 (en) 2017-11-02 2020-09-09 AiCuris GmbH & Co. KG Novel, highly active amino-thiazole substituted indole-2-carboxamides active against the hepatitis b virus (hbv)
SG11202003746UA (en) 2017-11-02 2020-05-28 Aicuris Gmbh & Co Kg Novel, highly active pyrazolo-piperidine substituted indole-2-carboxamides active against the hepatitis b virus (hbv)
CN112638883A (zh) * 2018-05-08 2021-04-09 爱尔兰詹森科学公司 二氢嘧啶衍生物及其在治疗hbv感染或hbv诱发疾病中的用途
US11053235B2 (en) 2018-08-09 2021-07-06 Janssen Sciences Ireland Unlimited Company Substituted 1,4-dihydropyrimidines for the treatment of HBV infection or HBV-induced diseases
AU2019373679A1 (en) 2018-11-02 2021-05-27 Aicuris Gmbh & Co. Kg Novel urea 6,7-dihydro-4H-thiazolo(5,4-c)pyridines active against the hepatitis B virus (HBV)
UY38437A (es) 2018-11-02 2020-05-29 Aicuris Gmbh & Co Kg Nuevas urea 6,7-dihidro-4h-pirazolo[1,5-a]pirazinas activas contra el virus de la hepatitis b (hbv)
UY38434A (es) 2018-11-02 2020-05-29 Aicuris Gmbh & Co Kg Nuevas 6,7-dihidro-4h-pirazolo[1,5-a]pirazin indol-2-carboxamidas activas contra el virus de la hepatitis b (hbv)
AR116948A1 (es) 2018-11-02 2021-06-30 Aicuris Gmbh & Co Kg Derivados de urea 6,7-dihidro-4h-pirazolo[1,5-a]pirazinas activas contra el virus de la hepatitis b (vhb)
AR116947A1 (es) 2018-11-02 2021-06-30 Aicuris Gmbh & Co Kg Derivados de urea 6,7-dihidro-4h-pirazolo[1,5-a]pirazinas-indol-2-carboxamidas activas contra el virus de la hepatitis b (vhb)
AR116946A1 (es) 2018-11-02 2021-06-30 Aicuris Gmbh & Co Kg Derivados de urea 6,7-dihidro-4h-pirazolo[4,3-c]piridinas activas contra el virus de la hepatitis b (vhb)
CN113227090A (zh) 2018-12-20 2021-08-06 詹森药业有限公司 杂芳基二氢嘧啶衍生物和治疗乙型肝炎感染的方法
MX2021013085A (es) 2019-04-30 2021-11-17 Aicuris Gmbh & Co Kg Nuevas indol-2-carboxamidas activas contra el virus de la hepatitis b (vhb).
EP3962909B1 (en) 2019-04-30 2023-10-04 AiCuris GmbH & Co. KG Novel oxalyl piperazines active against the hepatitis b virus (hbv)
EP3962912A1 (en) 2019-04-30 2022-03-09 AiCuris GmbH & Co. KG Novel phenyl and pyridyl ureas active against the hepatitis b virus (hbv)
US20220227789A1 (en) 2019-04-30 2022-07-21 Aicuris Gmbh & Co. Kg Novel indolizine-2-carboxamides active against the hepatitis b virus (hbv)
WO2020255016A1 (en) 2019-06-18 2020-12-24 Janssen Sciences Ireland Unlimited Company Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH550189A (de) 1971-01-08 1974-06-14 Ciba Geigy Ag Verfahren zur herstellung von neuen dibenzo (b,f) thiepincarbonsaeuren.
CH569043A5 (xx) 1973-01-23 1975-11-14 Ciba Geigy Ag
US4371537A (en) * 1981-08-13 1983-02-01 The Dow Chemical Company Sulfur-substituted phenoxypyridines having antiviral activity
DE3234684A1 (de) 1982-09-18 1984-03-22 Bayer Ag, 5090 Leverkusen Neue dihydropyrimidine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
JPS60185764A (ja) 1984-03-05 1985-09-21 Wako Pure Chem Ind Ltd ピリジン誘導体の新規な製造法
US4698340A (en) 1984-07-19 1987-10-06 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine derivatives, processes for preparation thereof and composition containing the same
US4727073A (en) 1984-10-01 1988-02-23 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine derivatives and composition of the same
GB8906168D0 (en) 1989-03-17 1989-05-04 Pfizer Ltd Therapeutic agents
AU725228B2 (en) 1996-11-12 2000-10-12 Novartis Ag Novel herbicides
SE9702564D0 (sv) * 1997-07-02 1997-07-02 Astra Ab New compounds

Also Published As

Publication number Publication date
JP5237332B2 (ja) 2013-07-17
BR9909730A (pt) 2000-12-19
JP2002512243A (ja) 2002-04-23
NZ507569A (en) 2002-04-26
CN1305471A (zh) 2001-07-25
HK1039119A1 (en) 2002-04-12
PE20000427A1 (es) 2000-06-25
EP1080086B1 (de) 2002-09-04
US20070117812A1 (en) 2007-05-24
GT199900056A (es) 2000-10-07
UA63998C2 (uk) 2004-02-16
BRPI9917862B8 (pt) 2021-05-25
CZ293482B6 (cs) 2004-05-12
NO20005215L (no) 2000-12-13
AU3813399A (en) 1999-11-08
US20040167135A1 (en) 2004-08-26
HUP0102372A3 (en) 2003-01-28
WO1999054326A8 (de) 1999-12-29
BG64649B1 (bg) 2005-10-31
JP4590097B2 (ja) 2010-12-01
BG104812A (en) 2001-06-29
TW548274B (en) 2003-08-21
NO329020B1 (no) 2010-07-26
BR9909730B1 (pt) 2012-09-04
PL193898B1 (pl) 2007-03-30
WO1999054326A1 (de) 1999-10-28
KR100636771B1 (ko) 2006-10-23
CA2328780C (en) 2008-09-23
BRPI9917862A2 (xx) 2010-12-07
PL343481A1 (en) 2001-08-27
DE19817264A1 (de) 1999-10-21
SI1080086T1 (en) 2003-02-28
AR018187A1 (es) 2001-10-31
DE59902573D1 (en) 2002-10-10
CN1159311C (zh) 2004-07-28
MY126527A (en) 2006-10-31
RU2245881C2 (ru) 2005-02-10
SK15652000A3 (sk) 2001-04-09
IL138584A0 (en) 2001-10-31
BRPI9917862B1 (pt) 2013-05-07
NO20045259L (no) 2000-12-13
JP2010241837A (ja) 2010-10-28
EP1080086A1 (de) 2001-03-07
NO321985B1 (no) 2006-07-31
CU23049A3 (es) 2005-06-24
RU2245881C9 (ru) 2006-02-10
ES2183548T3 (es) 2003-03-16
CA2328780A1 (en) 1999-10-28
KR20010042788A (ko) 2001-05-25
SV1999000047A (es) 2000-06-23
US7514565B2 (en) 2009-04-07
NO20005215D0 (no) 2000-10-17
CO5021127A1 (es) 2001-03-27
PT1080086E (pt) 2002-12-31
ZA200005136B (en) 2001-03-02
US6696451B1 (en) 2004-02-24
TR200003011T2 (tr) 2001-01-22
CZ20003871A3 (cs) 2001-01-17
SK286407B6 (sk) 2008-09-05
HUP0102372A2 (hu) 2001-12-28
IL138584A (en) 2006-09-05
AU740318B2 (en) 2001-11-01
DK1080086T3 (da) 2002-12-23
ATE223401T1 (de) 2002-09-15

Similar Documents

Publication Publication Date Title
ID27263A (id) Dihidropirimidina baru
ID17686A (id) Fotoinisiator alpha-aminoasetofenon baru
ID26308A (id) Dihidropirimidin baru yang tersubstitusi secara 2-heterosiklik
ID28240A (id) Turunan-turunan pirazol substitut baru
ID21881A (id) Turunan-turunan baru pirazol tersubstitusi
ATE341990T1 (de) Sigmidoskop
ID15840A (id) Turunan-turunan 19-nor-pregnena baru
DE59902874D1 (de) Buchsenkontakt
DE59901560D1 (de) Retrograder tibianagel
DE59907306D1 (de) Fadenchangierung
ID28286A (id) Antibiotik-antibiotik makrolida baru
DE59906931D1 (de) Exzenterzahnradgetriebe
ID18431A (id) Senyawa-senyawa baru
ID16660A (id) Senyawa-senyawa b-laktam monosiklik baru
NO981187D0 (no) Stöter
ID26299A (id) Herbisida baru
DE59903966D1 (de) Exzenterzahnradgetriebe
ATE262513T1 (de) Benzoylpyridazine
ID28624A (id) Turunan 2-fenilpiran-4-on
DE59903106D1 (de) Tripode-gleichlaufdrehgelenk
ID18262A (id) Turunan-turunan baru piranosida
DE59901046D1 (de) Methylcyclotetradec-5-en-1-one
ID24191A (id) Komposisi baru
ID19433A (id) Senyaw-senyawa baru
ID23647A (id) Komposisi-komposisi herbisida baru